A new COVID-19 therapy is available to people around New York.

The drug could help people who are immunocompromised have a better response to the COVID vaccine.

The drug is called Evusheld, a treatment of monoclonal antibodies that are delivered through a shot.

Mark Brooks is receiving it as part of a trial with Rochester Regional Health. He has a form of blood cancer and receives a blood infusion once a week. The hope is that the treatment will boost his immune system.

“The only immune system I really have, as far as my strength is from blood donors,” Brooks said.

“For this group if immune compromised people, they’ve done all of the things they can to protect themselves from COVID, but they’re still more vulnerable,” Dr. S. Shahzad Mustafa, lead physician of Allergy, Immunology & Rheumatology at Rochester region Health, said.

Anyone who is immunocompromised can talk with their doctor about receiving the drug.

Officials warn that it is currently in short supply. The federal government purchased 500,000 doses and has ordered 700,000 more.